Dr Ashraf Azzabi



GMC number: 5199658

Practicing since: 1992


Medical Oncology

Consultation times

  • Wednesday 17:30 - 18:30
  • Friday 17:30 - 18:30
  • Overview
Enquire now

Or call us on

0191 2816131


Dr Azzabi is a consultant medical oncologist with specialist interest in the non surgical treatments of colorectal and genitourinary cancers including Prostate, Urinary bladder, upper urinary tract, Kidney and germ cell cancers of testis. Dr Azzabi’s main practice is based at the Freeman Hospital but he also had practices at Sunderland Royal Infirmary and at South Tyneside District General Hospital

Dr Azzabi is actively involved, as a principal investigator, in a number of national and international clinical trials both in urological and colorectal cancers. He chaired the systemic therapies group at the cancer centre, the north east of England colorectal cancer tumour specific group. 

Dr Azazabi currently leads the late phase cancer research team at the northern centre for cancer care and has a role as the NIHR cancer research lead for the Newcastle upon Tyne hospitals NHS foundation Trust. He also has a role as the regional clinical lead for cancer research at the NIHR North east and North Cumbria research network.

Treatments and tests offered by Dr Ashraf Azzabi at Nuffield Health

  • Chemotherapy

Locations Dr Ashraf Azzabi works with

Related experience

Other posts held

  • Northern Centre for cancer care at Freeman Hospital
  • Consultant Medical Oncologist

Insurers Dr Ashraf Azzabi works with

Dr Ashraf Azzabi works with the following private medical insurance providers:

  • Aviva Health
  • AXA PPP Healthcare
  • Bupa
  • Simplyhealth


Dr Ashraf Azzabi does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.

Dr Ashraf Azzabi does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.

Dr Ashraf Azzabi does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.